Purple Biotech Ltd
F:1YI1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Purple Biotech Ltd
F:1YI1
|
IL |
|
Wolfden Resources Corp
F:WRC
|
CA |
|
MRM SA
F:8VV0
|
FR |
|
D
|
DMC Global Inc
F:DM5
|
US |
|
N
|
Nevada Exploration Inc
OTC:NVDEF
|
CA |
Shareholder Yield
Current shareholder yield for 1YI1 is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
1YI1 Price
Purple Biotech Ltd
| Average Annual Return | -37.33% |
| Standard Deviation of Annual Returns | 38.06% |
| Max Drawdown | -94% |
| Market Capitalization | 32.4m EUR |
| Shares Outstanding | 33 909 500 |
| Percentage of Shares Shorted |
N/A
|
1YI1 Return Decomposition
Main factors of price return
Stock Splits
1YI1's latest stock split occurred on Sep 17, 2024
The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.
Before the split, 1YI1 traded at 0.306 per share. Afterward, the share price was about 6.12.
The adjusted shares began trading on Sep 17, 2024. This was stock split number 2 in 1YI1's history, following the previous one in Aug 21, 2020.
